In focus
ABEC Launches ATB-2100 Bioreactor for Cell and Gene Therapy Manufacturing
ABEC has commercially launched the ATB-2100 Advanced Therapy Bioreactor, a single-use cell expansion platform it says supports cell growth from preclinical development through commercial manufacturing. The company says the system has demonstrated expansion of T-cells, iPSCs and MSCs.
Read the story